TrialProstate cancer and prostatic diseases2015

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy.

C G Roehrborn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.